Reflux esophagitis in patients with Zollinger-Ellison syndrome

Gastroenterology

Volumn 98, Issue 2, 1990, Pages 341-346

  Miller, L S ^a   Vinayek, R ^a   Frucht, H ^a   Gardner, J D ^a   Jensen, R T ^a   Maton, P N ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; ESOPHAGITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ACID; ZOLLINGER ELLISON SYNDROME;

ADULT; AGED; ESOPHAGITIS, PEPTIC; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMAN; MALE; MIDDLE AGE; OMEPRAZOLE; PARASYMPATHOLYTICS; ZOLLINGER-ELLISON SYNDROME;

EID: 0025058030     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(90)90823-J     Document Type: Article

References (28)

1. Zollinger-Ellison syndrome: current concepts in diagnosis and management
2. The Zollinger-Ellison syndrome. Reappraisal and evaluation of 260 registered cases
3. A reappraisal of clinical, roentgenographic, and endoscopic features of the Zollinger-Ellison syndrome
4. Zollinger-Ellison syndrome. Clinical features and long-term follow-up
5. The clinical diagnosis of the Zollinger-Ellison syndrome
6. The diagnosis of Zollinger-Ellison syndrome with special reference to the multiple endocrine adenomas
7. Relationship between lower esophageal spincter pressure and serum gastrin concentration in Zollinger-Ellison syndrome other clinical settings
8. Gastroesophageal reflux disease in the Zollinger-Ellison syndrome
9. 2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome
10. Effects of long term omeprazole on gastric acid secretion and mucosal histology in patients with Zollinger-Ellison syndrome (ZES) (abstract)
11. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome
12. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome
13. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study
14. Zollinger-Ellison syndrome. NIH combined clinical conference
15. Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man
16. A critical review of current medical therapy for gastroesophageal reflux disease
17. Ranitidine: a review of its pharmacology and therapeutic use in peptide ulcer disease and other allied diseases
18. Omeprazole and ranitidine in treatment of reflux oesophagitis—a double-blind comparative trial
19. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
20. Differences in healing tendency of reflux oesophagitis with omeprazole and ranitidine. Results of an Austrian-German-Swiss multicenter trial
21. Double-blind comparative study of omeprazole (40 mg OD) vs cimetidine (400 mg qds) in the treatment of erosive reflux esophagitis
22. Omeprazole versus ranitidine in erosive esophagitis: results of a French-Belgian multicentre study
23. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
24. Omeprazole or ranitidine in the treatment of reflux oesophagitis. Results from a double-blind, randomised, Scandinavian multicentre study
25. Omeprazole: a preliminary of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome
26. Relationship between gastric secretion and infection